Matthew Wilson

18PUBLICATIONS
93CO-AUTHORS
Haematological tumoursTumour immunologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Feb 12, 2026
Strategies for Managing Toxicities With High-Dose Methotrexate in Haematological Malignancies: Lessons From Clinical Cases.

Vanessa McLelland, Martin Guscott, Matthew R Wilson

|Nov 07, 2024
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.

Aisling Barrett, Nimish Shah, Andrew Chadwick

|Aug 11, 2024
Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper.

Matthew R Wilson, Kate Cwynarski, Toby A Eyre

|Jun 26, 2023
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.

Matthew R Wilson, Euan Haynes, Katrina Parsons

|Feb 22, 2023
How I manage mantle cell lymphoma: indolent versus aggressive disease.

Matthew R Wilson, Aisling Barrett, Chan Yoon Cheah

Pageof 3

Frequent Collaborators

11 joint publications

Pamela McKay

7 joint publications

Toby A Eyre

3 joint publications

Eric Durot

3 joint publications

Chan Yoon Cheah